Dr. Charles Fredrick Habekost is a Sonora, California based Periodontics who is specialized in Periodontology. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. Charles Fredrick Habekost is D31621 for Periodontology in California. His current practice location is 940 Sylva Ln Ste F1, Sonora. Patients can reach him at 209-533-0132.
Dr. Charles Fredrick Habekost is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Dr. Charles Fredrick Habekost speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1801079447
NPI Enumeration Date:
05 Dec, 2007
NPI Last Update On:
05 Dec, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Charles Fredrick Habekost are as mentioned below.
License Number
Specialization
State
Status
D31621
Periodontology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
940 Sylva Ln Ste F1, Sonora, California
Zip:
95370-5969
Patients can reach Dr. Charles Fredrick Habekost at 940 Sylva Ln Ste F1, Sonora, California or can call to book an appointment on 209-533-0132. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.